Skip to main content
David Relman, MD, Infectious Disease, Palo Alto, CA

DavidArnoldRelmanMD

Infectious Disease Palo Alto, CA

Professor, Medicine - Infectious Diseases, Stanford University Medical

Are you Dr. Relman?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    3801 Miranda Ave
    154t
    Palo Alto, CA 94304
    Phone+1 650-852-3308

Summary

  • Dr. David Relman, MD is an infectious disease specialist in Palo Alto, California. He is currently licensed to practice medicine in California. He is a Professor at Stanford University Medical.

Education & Training

  • Harvard Medical School
    Harvard Medical SchoolClass of 1982

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1986 - 2026
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

Press Mentions

  • NIH Cancels ‘Havana Syndrome’ Research, Citing Unethical Coercion of Participants
    NIH Cancels ‘Havana Syndrome’ Research, Citing Unethical Coercion of ParticipantsSeptember 1st, 2024
  • Theodor Diener, Who Discovered the Tiniest of Infectious Agents, Dies at 102
    Theodor Diener, Who Discovered the Tiniest of Infectious Agents, Dies at 102May 8th, 2023
  • Monday, Feb 27 2023
    Monday, Feb 27 2023February 27th, 2023
  • Join now to see all

Grant Support

  • Applied Genomics in Infectious DiseasesSTANFORD UNIVERSITY1995–2027
  • Household transmission of the human gut microbiota after antibiotic exposureSTANFORD UNIVERSITY2022–2025
  • Antimicrobial Resistance and Horizontal Gene Transfer in the Human Gut Microbiome in Response to an AntibioticPALO ALTO VETERANS INSTIT FOR RESEARCH2020–2025